BRUSSELS, March 15 (Reuters) - Johnson & Johnson is set to gain EU approval for its planned $21.3 billion buy of Swiss medical devices maker Synthes after offering concessions to address concerns over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback